Recall

Ajanta Pharma USA Inc: Fenofibrate Capsules, USP 200 mg, Rx only, 100 Capsules, Recall

CGMP Deviations Product details: Fenofibrate Capsules, USP 200 mg, Rx only, 100 Capsules, Manufactured by: Ajanta Pharma Limited, India, Marketed by: Ajanta Pharma USA Inc. Bridgewater, NJ 08807, NDC 27241-120-04.

Active Official source

Verification

Official-source record

This page is included in the public index because it is tied to a listed official source. ClaimWatch does not publish trend-only candidates to public SEO pages.

Agency
FDA
Record ID
D-0611-2026
Canonical
https://claimwatch-mvp.vercel.app/item/ajanta-pharma-usa-inc-fenofibrate-capsules-usp-200-mg-rx-only-100-capsules/

What happened?

CGMP Deviations Product details: Fenofibrate Capsules, USP 200 mg, Rx only, 100 Capsules, Manufactured by: Ajanta Pharma Limited, India, Marketed by: Ajanta Pharma USA Inc. Bridgewater, NJ 08807, NDC 27241-120-04.

Who may be affected?

U.S. Nationwide

What should consumers do?

Affected quantity: 3648 bottles

Matched search terms

No search trend terms attached yet.

FAQ

Is this page official?

No. ClaimWatch links to official sources and marks whether a page is verified or still being monitored.

Is this legal, medical, or financial advice?

No. This page is informational. Always confirm eligibility, deadlines, and safety instructions through official sources.

Similar alerts